Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults
Condition(s):Myelodysplastic/Myeloproliferative Neoplasms; AdultLast Updated:March 16, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic/Myeloproliferative Neoplasms; AdultLast Updated:March 16, 2022Unknown status
Condition(s):Polycythemia Vera; Essential Thrombocytosis; Idiopathic Myelofibrosis; Neutrophils; Chronic Myeloproliferative DisordersLast Updated:July 2, 2017Completed
Condition(s):Myeloproliferative NeoplasmLast Updated:October 31, 2018Completed
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative DiseasesLast Updated:April 2, 2010Completed
Condition(s):Chronic Myeloproliferative DisordersLast Updated:January 13, 2012Terminated
Condition(s):Myeloproliferative Neoplasm; Secondary LeukemiaLast Updated:September 1, 2023Not yet recruiting
Condition(s):Chronic Myeloproliferative DisordersLast Updated:June 17, 2010Completed
Condition(s):Myeloproliferative Neoplasms (MPNs)Last Updated:July 25, 2023Recruiting
Condition(s):Bone Marrow Fibrosis; Myeloproliferative NeoplasmLast Updated:October 11, 2023Withdrawn
Condition(s):Myeloproliferative NeoplasmsLast Updated:February 28, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.